STOCK TITAN

Limbach Holdings (LMB) Form 4 Filings

LMB NASDAQ

Here are the Form 4 insider transactions from Limbach Holdings, Inc (LMB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow LMB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LMB filings page.

Rhea-AI Summary

Limbach Holdings, Inc. (LMB) reported an insider sale by Executive Vice President Jay Sharp. On September 15, 2026, Sharp sold 5,094 shares of common stock at $50.21 per share in an open-market or private transaction pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026. After this sale, Sharp directly holds 67,642 shares of Limbach common stock.

Rhea-AI Summary

Limbach Holdings, Inc. (LMB) director Laurel J. Krzeminski reported purchasing 500 shares of common stock on September 15, 2026 at $50.575 per share, through an indirect holding in a SEP IRA. After this purchase, reported holdings include 4,000 shares in the SEP IRA, 1,500 shares held directly, and 31,452 shares held indirectly through the Laurel J. Krzeminski Revocable Trust. A footnote states that recent changes reflect a reclassification of how these holdings are presented and do not change aggregate beneficial ownership, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

Limbach Holdings, Inc. (LMB) director David Richard Gaboury purchased additional common stock in the company. On September 14, 2026, he bought 1,940 shares of common stock at $51.35 per share in an open-market or private transaction, bringing his directly held stake to 7,193 shares.

Rhea-AI Summary

Limbach Holdings, Inc. (LMB) had director Joshua Horowitz and affiliated Palm Global Small Cap Master Fund LP report open-market purchases of an aggregate 7,820 shares of Common Stock on September 11 and September 15, 2026.

Horowitz bought shares directly, while additional shares were purchased indirectly through Palm Global, at prices generally between $48.88 and $51.25 per share. Palm Management (US) LLC and Horowitz may be deemed beneficial owners of Palm Global’s shares but expressly disclaim beneficial ownership except to the extent of their pecuniary interest.

Rhea-AI Summary

Limbach Holdings, Inc. Executive Vice President Jay Sharp reported multiple stock transactions. On June 15, 2026, he sold a total of 4,871 shares of common stock in several open‑market trades at weighted average prices between $78.46 and $81.32, and made a bona fide gift of 720 shares for no consideration.

The filing notes that one transaction is part of a Rule 10b5-1 trading plan adopted on March 14, 2026, indicating a pre‑arranged selling program. After these transactions, Sharp directly holds 72,736 shares of Limbach common stock.

Rhea-AI Summary

Reed Michael James reported acquisition or exercise transactions in this Form 4 filing.

Limbach Holdings, Inc. reported that Chief Operating Officer Michael James Reed received a grant of 403 restricted stock units (RSUs) on May 18, 2026. These RSUs vest in three annual installments on May 18, 2027, May 18, 2028, and May 18, 2029, subject to continued employment.

The filing also shows he directly holds 3,507 shares of common stock after the reported transactions. Earlier RSU awards granted in 2024, 2025 and 2026 are scheduled to vest in tranches of 689 shares on January 1, 2027, 468 shares on January 1, 2028, and 268 shares on January 1, 2029, all subject to service-based vesting conditions.

The company notes that any performance-based or market-based RSUs that may be earned, but whose performance outcomes are not yet determined, will be reported later on separate Forms 4. No open‑market purchases or sales are reported in this filing.

Rhea-AI Summary

Limbach Holdings, Inc. Chief Financial Officer Jayme L. Brooks reported an open-market sale of 3,440 shares of common stock at $100 per share on April 30, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted on December 16, 2025.

After this sale, Brooks directly holds 125,227 shares of common stock. An additional 3,897 shares are held indirectly by the Brooks Family Trust, where Brooks and her spouse serve as trustees, with beneficial ownership of those trust shares disclaimed except to the extent of her pecuniary interest.

Rhea-AI Summary

Limbach Holdings Chief Financial Officer Jayme L. Brooks reported an open-market sale of company stock. On April 24, 2026, she sold 2,173 shares of Limbach Holdings common stock at a weighted average price of $100.0516 per share in a transaction coded as an open-market sale.

The filing states that this sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on December 16, 2025, and occurred through multiple trades between $100.00 and $100.50 per share. After the sale, Brooks directly held 128,667 shares of common stock. The report also shows 3,897 shares held indirectly by the Brooks Family Trust, for which she and her spouse serve as trustees and where she disclaims beneficial ownership beyond her pecuniary interest.

Rhea-AI Summary

Limbach Holdings, Inc. Chief Financial Officer Jayme L. Brooks sold 5,703 shares of common stock in an open-market transaction at a weighted average price of $85.4269 per share on April 13, 2026. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on December 16, 2025. After this transaction, Brooks directly holds 130,840 shares. An additional 3,897 shares are reported as held indirectly through the Brooks Family Trust, for which she and her spouse serve as trustees and where she disclaims beneficial ownership except for any pecuniary interest.

Rhea-AI Summary

Limbach Holdings, Inc. Chief Financial Officer Jayme L. Brooks reported open‑market sales of company stock under a pre‑arranged Rule 10b5‑1 trading plan. She sold 3,366 shares of common stock on April 8, 2026 at a weighted average price of about $85.19 per share and 841 shares on April 9, 2026 at about $85.11 per share, totaling 4,207 shares sold.

After these transactions, she directly holds 136,543 shares of Limbach common stock. In addition, 3,897 shares are held indirectly by the Brooks Family Trust, where she and her spouse serve as trustees, with beneficial ownership of those trust shares disclaimed except for her pecuniary interest.

Rhea-AI Summary

Limbach Holdings Chief Financial Officer Jayme L. Brooks reported open-market sales of company stock under a pre-arranged Rule 10b5-1 trading plan. On March 17, 2026, she sold a total of 9,910 shares of common stock in multiple transactions at weighted average prices ranging from $77.1047 to $81.4030 per share. Following these sales, Brooks directly holds 140,750 shares of Limbach common stock and has an additional 3,897 shares reported as indirectly held through the Brooks Family Trust, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.

Rhea-AI Summary

Limbach Holdings, Inc. Executive Vice President Jay Sharp reported multiple insider transactions in the company’s common stock. On March 16, 2026, he sold a total of 2,000 shares in open-market trades at weighted average prices ranging from $78.6122 to $81.6551 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025. He also made a bona fide gift of 700 shares for which he received no payment or consideration. After these transactions, he directly holds 78,327 shares of Limbach common stock.

Rhea-AI Summary

Limbach Holdings, Inc. Executive Vice President Jay Sharp reported two related stock transactions. He received a grant of 28,747 shares of common stock on March 2, 2026 upon vesting of performance-based restricted stock units tied to goals for 2023–2025. The company then withheld 12,359 shares at $89.17 per share to cover tax obligations. After these transactions, he directly owned 81,027 common shares.

Rhea-AI Summary

Limbach Holdings, Inc. Chief Financial Officer Jayme L. Brooks received 40,835 shares of common stock on March 2, 2026, from the vesting of performance-based restricted stock units tied to 2023–2025 goals. The company withheld 16,070 shares to cover taxes, leaving her with 150,660 directly held shares and 3,897 shares held indirectly through the Brooks Family Trust.

Rhea-AI Summary

Limbach Holdings, Inc. reported that Chief Executive Officer Michael M. McCann received an equity award of 52,008 shares of common stock on March 2, 2026, issued at $0.00 per share upon vesting of 34,672 performance-based restricted stock units tied to above-target goals for the 2023–2025 period. To cover tax withholding obligations, 20,466 shares were withheld by the company at $89.17 per share, reducing his directly held balance to 167,514 shares. In addition, 44,233 shares are reported as held indirectly through The McCann Family Revocable Living Trust, for which McCann and his spouse serve as trustees and where he disclaims beneficial ownership except for his pecuniary interest.

Rhea-AI Summary

Limbach Holdings Executive Vice President Nicholas Angerosa reported equity compensation activity involving company common stock. He received a grant of 22,559 shares of common stock on March 2, 2026, issued upon vesting of 15,040 performance-based restricted stock units tied to performance from January 1, 2023 through December 31, 2025.

The filing also shows a disposition of 8,878 shares on the same date to cover tax withholding obligations, with shares withheld by the company rather than sold on the open market. After these transactions, Angerosa directly owned 67,639 common shares.

Rhea-AI Summary

Limbach Holdings, Inc. director Terence Patrick Dugan reported an equity award on a Form 4. On January 20, 2026, he was granted 1,498 restricted stock units (RSUs), each representing a contingent right to receive one share of Limbach Holdings common stock. The RSUs were awarded at an exercise price of $0 and are scheduled to cliff vest on January 1, 2027, meaning all units vest at once on that date rather than gradually. Following this grant, Dugan beneficially owns 1,498 derivative securities directly, reflecting this new RSU award.

Rhea-AI Summary

Limbach Holdings, Inc. Chief Financial Officer Jayme L. Brooks reported a charitable stock gift. On 12/16/2025, she made a bona fide gift of 614 shares of Limbach common stock, reported at a price of $0 per share, to a donor-advised charitable fund. Following this transaction, she reported 3,897 shares held indirectly through the Brooks Family Trust and 122,102 shares held directly.

The shares held by the Brooks Family Trust are reported as indirectly owned, with the reporting person and her spouse serving as trustees. She disclaims beneficial ownership of these trust-held shares except to the extent of her pecuniary interest in them.

Rhea-AI Summary

Limbach Holdings, Inc. regional president Jay A. Sharp reported recent personal transactions in the company’s common stock. On December 12, 2025, he made a bona fide gift of 410 shares for which he received no payment, and his directly beneficially owned position stood at 66,979 shares afterward.

On December 15, 2025, Sharp sold multiple blocks of common stock under a Rule 10b5-1 trading plan adopted on March 14, 2025, including transactions of 900, 500, 500 and 100 shares at weighted average prices of $77.2478, $77.8588, $78.9871 and $80.05, respectively. After these sales he directly owned 64,979 shares, which include restricted stock units granted in January 2023 that are scheduled to vest in the aggregate for 3,194 shares on January 1, 2026, subject to service-based conditions; any performance-based RSUs are not yet included.